Cargando…

Association of statin and/or renin-angiotensin-aldosterone system modulating therapy with mortality in adults with diabetes admitted to hospital with COVID-19: A retrospective multicentre European study

BACKGROUND & AIMS: To assess the impact of pre-admission renin-angiotensin-aldosterone system inhibitor (RAASi) and statin use on mortality following COVID-19 hospitalization in adults with pre-existing diabetes. METHODS: Retrospective cohort study of adults with diabetes admitted to ninety-nine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harris, Sophie, Ruan, Yue, Wild, Sarah H., Wargny, Matthieu, Hadjadj, Samy, Delasalle, Béatrice, Saignes, Maëva, Ryder, Robert EJ., Field, Benjamin C.T., Narendran, Parth, Zaccardi, Francesco, Wilmot, Emma G., Vlacho, Bogdan, Llauradó, Gemma, Mauricio, Didac, Nagi, Dinesh, Patel, Dipesh, Várnai, Kinga A., Davies, Jim, Gourdy, Pierre, Cariou, Bertrand, Rea, Rustam, Khunti, Kamlesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Diabetes India. Published by Elsevier Ltd. 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996468/ https://www.ncbi.nlm.nih.gov/pubmed/35472685 http://dx.doi.org/10.1016/j.dsx.2022.102484

Ejemplares similares

The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19)
por: Llauradó, Gemma, et al.
Publicado: (2022)

Associations of microvascular complications with all‐cause death in patients with diabetes and COVID‐19: The CORONADO, ABCD COVID‐19 UK national audit and AMERICADO study groups
por: Hadjadj, Samy, et al.
Publicado: (2022)

Comment on Chen et al. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication. Diabetes Care 2020;43:1399–1407
por: Cariou, Bertrand, et al.
Publicado: (2020)

Diabète et COVID-19 : les leçons de CORONADO
por: Cariou, Bertrand, et al.
Publicado: (2021)

COVID-19 and Diabetes Outcomes: Rationale for and Updates from the CORONADO Study
por: Smati, Sarra, et al.
Publicado: (2022)

A UK nationwide study of people with type 1 diabetes admitted to hospital with COVID-19 infection
por: Ruan, Yue, et al.
Publicado: (2021)

Phenotypic characteristics and prognosis of newly diagnosed diabetes in hospitalized patients with COVID-19: Results from the CORONADO study
por: Cariou, Bertrand, et al.
Publicado: (2021)

Risk of Diabetes Following COVID-19: Translating Evidence Into Clinical and Public Health Actions
por: Zaccardi, Francesco, et al.
Publicado: (2022)

All‐cause and cardiorenal mortality in 6 million adults with and without type 2 diabetes: A comparative, trend analysis in Canada, Spain, and the UK
por: Ling, Suping, et al.
Publicado: (2022)

Type 1 Diabetes in People Hospitalized for COVID-19: New Insights From the CORONADO Study
por: Wargny, Matthieu, et al.
Publicado: (2020)

Comorbidities, complications and mortality in people of South Asian ethnicity with type 1 diabetes compared with other ethnic groups: a systematic review
por: Sarwar, Komil N, et al.
Publicado: (2017)

Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO study
por: Cariou, Bertrand, et al.
Publicado: (2021)

Glucose-lowering treatments and COVID-19 mortality in T2DM
por: Hadjadj, Samy, et al.
Publicado: (2021)

Response to letter to the editor by Abhipsha Sur Roy and Amol Joshi regarding the article: ‘Multimorbidity and SARS-CoV-2 infection in UK Biobank’ (Chudasama et al.)
por: Chudasama, Yogini V, et al.
Publicado: (2020)

Safety of antidepressants in a primary care cohort of adults with obesity and depression
por: Morriss, Richard, et al.
Publicado: (2021)

Analysis of the Adherence and Safety of Second Oral Glucose-Lowering Therapy in Routine Practice From the Mediterranean Area: A Retrospective Cohort Study
por: Vlacho, Bogdan, et al.
Publicado: (2021)

Non‐inferiority and clinical superiority of glucagon‐like peptide‐1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors: Systematic analysis of cardiorenal outcome trials in type 2 diabetes
por: Zaccardi, Francesco, et al.
Publicado: (2022)

La metformine est associée à une moindre mortalité chez les patients diabétiques hospitalisés pour la COVID-19
por: Lalau, Jean-Daniel, et al.
Publicado: (2021)

Severe hypoglycaemia and absolute risk of cause-specific mortality in individuals with type 2 diabetes: a UK primary care observational study
por: Zaccardi, Francesco, et al.
Publicado: (2020)

Obesity and risk of COVID-19: analysis of UK biobank
por: Yates, Thomas, et al.
Publicado: (2020)

Kidney Function and Long-Term Risk of End-Stage Kidney Disease and Mortality in a Multiethnic Population
por: Ling, Suping, et al.
Publicado: (2023)

Plasma apolipoprotein concentrations and incident diabetes in subjects with prediabetes
por: Croyal, Mikaël, et al.
Publicado: (2022)

Effect of Flash Glucose Monitoring on Glycemic Control, Hypoglycemia, Diabetes-Related Distress, and Resource Utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit
por: Deshmukh, Harshal, et al.
Publicado: (2020)

Fatty liver index is a strong predictor of changes in glycemic status in people with prediabetes: The IT-DIAB study
por: Wargny, Matthieu, et al.
Publicado: (2019)

Global burden of hypoglycaemia-related mortality in 109 countries, from 2000 to 2014: an analysis of death certificates
por: Zaccardi, Francesco, et al.
Publicado: (2018)

Inequalities in cancer mortality trends in people with type 2 diabetes: 20 year population-based study in England
por: Ling, Suping, et al.
Publicado: (2023)

Risk factors for severe outcomes in people with diabetes hospitalised for COVID-19: a cross-sectional database study
por: Ortega, Emilio, et al.
Publicado: (2021)

The importance of the initial period of basal insulin titration in people with diabetes
por: Khunti, Kamlesh, et al.
Publicado: (2020)

Previous Vitamin D Supplementation and Morbidity and Mortality Outcomes in People Hospitalised for COVID19: A Cross-Sectional Study
por: Arroyo-Díaz, Juan Antonio, et al.
Publicado: (2021)

Impaired Awareness of Hypoglycemia and Severe Hypoglycemia in Drivers With Diabetes: Insights From the Association of British Clinical Diabetologists Nationwide Audit
por: Deshmukh, Harshal, et al.
Publicado: (2021)

Prediction of type 2 diabetes risk in people with non-diabetic hyperglycaemia: model derivation and validation using UK primary care data
por: Coles, Briana, et al.
Publicado: (2020)

Cardiovascular events and mortality in people with and without type 2 diabetes: An observational study in a contemporary multi‐ethnic population
por: Coles, Briana, et al.
Publicado: (2020)

Efficacy and safety of sodium-glucose cotransporter 2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes: a systematic review and network meta-analysis study protocol
por: Hussein, Humaira, et al.
Publicado: (2018)

Where Does Metformin Stand in Modern Day Management of Type 2 Diabetes?
por: Ahmad, Ehtasham, et al.
Publicado: (2020)

Use of Metformin and Cardiovascular Effects of New Classes of Glucose-Lowering Agents: A Meta-analysis of Cardiovascular Outcome Trials in Type 2 Diabetes
por: Zaccardi, Francesco, et al.
Publicado: (2021)

Association of Ethnicity and Socioeconomic Status With COVID-19 Hospitalization and Mortality in Those With and Without Chronic Kidney Disease
por: Wilkinson, Thomas J., et al.
Publicado: (2021)

Nutritional biomarkers and heart failure requiring hospitalization in patients with type 2 diabetes: the SURDIAGENE cohort
por: Wargny, Matthieu, et al.
Publicado: (2022)

Long terms trends of multimorbidity and association with physical activity in older English population
por: Dhalwani, Nafeesa N., et al.
Publicado: (2016)

Relationship of cardiometabolic parameters in non-smokers, current smokers, and quitters in diabetes: a systematic review and meta-analysis
por: Kar, Debasish, et al.
Publicado: (2016)

Trends in Cause-Specific Outcomes Among Individuals With Type 2 Diabetes and Heart Failure in the United Kingdom, 1998-2017
por: Lawson, Claire A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_51i5hl430m6tpn3v41b1rv8qac